e_g_mosquitoes_gnats_and_flies_clinical_condition_per_nice_nice_cks_guidance_term_insect_includes paragraph • ordinal 1 Up Down Delete Body Key Type paragraphbulletheadingtable_rownote Category Parent Key Checkable item Text : “† As per NICE and NICE CKS guidance, the term “insect” includes those with six legs (e.g. mosquitoes, gnats and flies) and those with eight legs (e.g. spiders, mites and ticks).” Markdown : “† As per NICE and NICE CKS guidance, the term “insect” includes those with six legs (e.g. mosquitoes, gnats and flies) and those with eight legs (e.g. spiders, mites and ticks).”
e_g_mosquitoes_gnats_and_flies_clinical_condition_exclusion_criterion_amended_bite_sting_occurred_while_travelling bullet • ordinal 2 Up Down Delete Body Key Type paragraphbulletheadingtable_rownote Category Parent Key Checkable item Text Exclusion criterion amended from “Bite or sting occurred while travelling outside the UK” to “Bite or sting occurred while travelling outside the UK with concern of insect borne disease e.g. malaria, tick borne encephalitis” Markdown Exclusion criterion amended from “Bite or sting occurred while travelling outside the UK” to “Bite or sting occurred while travelling outside the UK with concern of insect borne disease e.g. malaria, tick borne encephalitis”
e_g_mosquitoes_gnats_and_flies_clinical_condition_addition group • ordinal 3 Up Down Delete Body Key Type paragraphbulletheadingtable_rownote Category Parent Key Checkable item Text Addition of: Markdown Addition of:
e_g_mosquitoes_gnats_and_flies_clinical_condition_lomitapide bullet • ordinal 4 Up Down Delete Body Key Type paragraphbulletheadingtable_rownote Category Parent Key Checkable item Text “Lomitapide Markdown - “Lomitapide
e_g_mosquitoes_gnats_and_flies_clinical_condition_medicines_where_concomitant_use_moderate_cyp_3a4_inhibitor bullet • ordinal 5 Up Down Delete Body Key Type paragraphbulletheadingtable_rownote Category Parent Key Checkable item Text Medicines where concomitant use with a moderate CYP 3A4 inhibitor (i.e. erythromycin) is contraindicated (e.g. ▪ Lercanidipine ▪ Ivabradine ▪ Quetiapine) Version: 1.1 Reference Number: 4c Valid from: 01/10/2025 Review date: 30/04/2027 Expiry date: 30/09/2028 Markdown - Medicines where concomitant use with a moderate CYP 3A4 inhibitor (i.e. erythromycin) is contraindicated (e.g. ▪ Lercanidipine ▪ Ivabradine ▪ Quetiapine) Version: 1.1 Reference Number: 4c Valid from: 01/10/2025 Review date: 30/04/2027 Expiry date: 30/09/2028
e_g_mosquitoes_gnats_and_flies_clinical_condition_other_medicine_where_concomitant_use_erythromycin_contraindicated bullet • ordinal 6 Up Down Delete Body Key Type paragraphbulletheadingtable_rownote Category Parent Key Checkable item Text Any other medicine where concomitant use with erythromycin is contraindicated” to “ Markdown - Any other medicine where concomitant use with erythromycin is contraindicated” to “